Dalton Transactions · 2011 · 86 citations · 40 references
PharmacyChemistryMedicinal ChemistryCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsChemical Library DesignHeterocyclic ChemistryLead Compound DesignNanomedicineStructure-activity Relationship AnalysisActivitiesAnticancer ActivityAnticancer ChemotherapyChemical Structure-activity RelationshipsMedicinal HeterocyclesOrganoruthenium ChemistryPhysicochemical PropertiesRedox Potential
A library of 32 organoruthenium compounds has been synthesised. Known and novel C-N cyclometalated compounds as well as N-C-N and N-N-C pincer derivatives of this metal have been used in this purpose. Most of the compounds have been tested for their in vitro antitumoral behaviours, good to excellent activities have thus been found. Several of the newly synthesized compounds pass the symbolic barrier of the nanomolar range for their IC(50) indicating a critical improvement. The level of activity is tentatively correlated to physicochemical properties of the compounds such as their Ru(III/II) redox potential and their lipophilicity (log P).
40
Areneruthenium complexes as anticancer agents
Georg Süß‐Fink · Dalton Transactions · 2009 · 635 citations
J. A. Gareth Williams, Andrew Beeby, E. Stephen Davies et al. · Inorganic Chemistry · 2003 · 386 citations
Benzene Complexes of Ruthenium(II)
R. A. Zelonka, Michael C. Baird · Canadian Journal of Chemistry · 1972 · 373 citations · Full text
Ulrich Schatzschneider, Johanna Niesel, Ingo Ott et al. · ChemMedChem · 2008 · 263 citations
Medicine, Oncology, Pharmacology +13